Prospectus supplement US007924AH66 - Aegon
Prospectus supplement US007924AH66 - Aegon
Prospectus supplement US007924AH66 - Aegon
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
• Report on Form 6-K furnished to the SEC on August 31, 2009 relating to the completion of the<br />
sale of our Taiwanese life insurance activities;<br />
• Report on Form 6-K furnished to the SEC on September 23, 2009 with our unaudited<br />
condensed consolidated interim financial statements and Operating and Financial Review and<br />
Prospects for the six month period ended June 30, 2009;<br />
• Report on Form 6-K furnished to the SEC on October 13, 2009 relating to our completion of an<br />
approximately $650 million capital management transaction with JPMorgan Chase Bank;<br />
• Report on Form 6-K furnished to the SEC on October 29, 2009 relating to our plan to repay<br />
A1 billion to the Dutch State;<br />
• Report on Form 6-K furnished to the SEC on November 20, 2009 with our unaudited condensed<br />
consolidated interim financial statements for the nine month period ended September 30, 2009;<br />
• Report on Form 6-K furnished to the SEC on November 23, 2009 with a presentation of our<br />
third quarter 2009 financial results, intended solely for incorporation into the registration<br />
statement of which this prospectus <strong>supplement</strong> forms a part; and<br />
• each of the following documents that we file with or furnish to the SEC after the date of this<br />
prospectus <strong>supplement</strong> from now until we terminate the offering of securities under this<br />
prospectus <strong>supplement</strong>, the accompanying prospectus and the registration statement:<br />
• reports filed under Section 13(a), 13(c) or 15(d) of the Exchange Act, and<br />
• reports filed or furnished on Form 6-K that indicate that they are incorporated by reference<br />
in this prospectus <strong>supplement</strong> or the accompanying prospectus.<br />
These documents contain important information about us and our financial condition. You may<br />
obtain copies of these documents in the manner described above. You may also request a copy of these<br />
filings (excluding exhibits) at no cost by contacting us as follows:<br />
Investor Relations<br />
Investor Relations<br />
AEGON USA, Inc.<br />
AEGON N.V.<br />
1111 North Charles Street P.O. Box 85<br />
Baltimore, MD 21201<br />
2501 CB The Hague<br />
USA<br />
The Netherlands<br />
Tel: 1-410-576-4577 Tel: 011-31-70-344-8305<br />
Fax: 1-410-347-8685 Fax: 011-31-70-344-8445<br />
E-mail: ir@aegonusa.com<br />
E-mail: groupir@aegon.com<br />
S-7